{"id":2620,"date":"2016-04-28T09:49:26","date_gmt":"2016-04-28T08:49:26","guid":{"rendered":"http:\/\/medicine.st-andrews.ac.uk\/?p=2620"},"modified":"2016-04-28T09:49:26","modified_gmt":"2016-04-28T08:49:26","slug":"mrs-commercial-training-event","status":"publish","type":"post","link":"https:\/\/medicine.st-andrews.ac.uk\/news\/mrs-commercial-training-event\/","title":{"rendered":"MRS Commercial Training Event"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2621 alignleft\" src=\"https:\/\/medicine.st-andrews.ac.uk\/medicine\/wp-content\/uploads\/sites\/30\/2016\/04\/MRS.jpg\" alt=\"MRS\" width=\"200\" height=\"200\" \/>Awa Sarr (Dr Reynolds group, School of medicine) attended the annual Commercial Training Event for PhD students organised by Medical Research Scotland (Perth, the 19 and 20 April 2016). This event promotes university and industrial partnership.<\/p>\n<p>She presented a poster of her research project entitled: \u201cResistance mechanisms to Gemcitabine and Acelarin in pancreatic cancer\u201d.<\/p>\n<p>This project is a collaboration between the University of Saint-Andrews and the ph<img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2622 alignright\" src=\"https:\/\/medicine.st-andrews.ac.uk\/medicine\/wp-content\/uploads\/sites\/30\/2016\/04\/NUCANA.jpg\" alt=\"NUCANA\" width=\"225\" height=\"225\" \/>armaceutical company Nucana Ltd. It aims at identifying genes and cellular pathways involved in the pancreatic cancer cell resistance to Gemcitabine (current standard treatment) and its analogue Acelarin (Nucana) treatment using the CRISPR\/Cas9 system.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Awa Sarr recently attended the annual Commercial Training Event for PhD students organised by Medical Research Scotland.  She presented a poster of her research project entitled: \u201cResistance mechanisms to Gemcitabine and Acelarin in pancreatic cancer\u201d.<\/p>\n","protected":false},"author":39,"featured_media":2621,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[10,1],"tags":[113,170,372,717],"class_list":["post-2620","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-uncategorised","tag-awa-sarr","tag-cancer","tag-dr-paul-reynolds","tag-medical-research-scotland"],"publishpress_future_action":{"enabled":false,"date":"2026-04-20 21:46:46","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/posts\/2620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/comments?post=2620"}],"version-history":[{"count":0,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/posts\/2620\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/media\/2621"}],"wp:attachment":[{"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/media?parent=2620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/categories?post=2620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicine.st-andrews.ac.uk\/news\/wp-json\/wp\/v2\/tags?post=2620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}